BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3670291)

  • 1. SVA retrotransposons as modulators of gene expression.
    Quinn JP; Bubb VJ
    Mob Genet Elements; 2014; 4():e32102. PubMed ID: 25077041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of monoamine transporters: relevance to brain disorders.
    Haddley K; Vasiliou AS; Ali FR; Paredes UM; Bubb VJ; Quinn JP
    Neurochem Res; 2008 Apr; 33(4):652-67. PubMed ID: 17960477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.
    Guindalini C; Howard M; Haddley K; Laranjeira R; Collier D; Ammar N; Craig I; O'Gara C; Bubb VJ; Greenwood T; Kelsoe J; Asherson P; Murray RM; Castelo A; Quinn JP; Vallada H; Breen G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4552-7. PubMed ID: 16537431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte maturation controls expression of equine infectious anemia virus.
    Maury W
    J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple protein-binding sites in an intracisternal A particle long terminal repeat.
    Falzon M; Kuff EL
    J Virol; 1988 Nov; 62(11):4070-7. PubMed ID: 3139894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.
    Gimble JM; Duh E; Ostrove JM; Gendelman HE; Max EE; Rabson AB
    J Virol; 1988 Nov; 62(11):4104-12. PubMed ID: 2845125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancer kappa E2 site.
    Gimble JM; Flanagan JR; Recker D; Max EE
    Nucleic Acids Res; 1988 Jun; 16(11):4967-88. PubMed ID: 2838809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer.
    Quinn JP; Farina AR; Gardner K; Krutzsch H; Levens D
    Mol Cell Biol; 1989 Nov; 9(11):4713-21. PubMed ID: 2601694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient expression analysis of the reticuloendotheliosis virus long terminal repeat element.
    Ridgway AA; Kung HJ; Fujita DJ
    Nucleic Acids Res; 1989 Apr; 17(8):3199-215. PubMed ID: 2542893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.
    Schmidt A; Hennighausen L; Siebenlist U
    J Virol; 1990 Aug; 64(8):4037-41. PubMed ID: 2196387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
    Parrott C; Seidner T; Duh E; Leonard J; Theodore TS; Buckler-White A; Martin MA; Rabson AB
    J Virol; 1991 Mar; 65(3):1414-9. PubMed ID: 1995951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
    Vacca A; Felli MP; Farina AR; Martinotti S; Maroder M; Screpanti I; Meco D; Petrangeli E; Frati L; Gulino A
    J Exp Med; 1992 Mar; 175(3):637-46. PubMed ID: 1740658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of a cellular protein to the gibbon ape leukemia virus enhancer.
    Quinn JP; Holbrook N; Levens D
    Mol Cell Biol; 1987 Aug; 7(8):2735-44. PubMed ID: 3670291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-acting transcriptional regulatory sequences in the gibbon ape leukemia virus (GALV) long terminal repeat.
    Holbrook NJ; Gulino A; Ruscetti F
    Virology; 1987 Mar; 157(1):211-9. PubMed ID: 3029959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence of the large terminal repeat of two different strains of gibbon ape leukemia virus.
    Trainor CD; Scott ML; Josephs SF; Fry KE; Reitz MS
    Virology; 1984 Aug; 137(1):201-5. PubMed ID: 6474832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers.
    Quinn JP; Takimoto M; Iadarola M; Holbrook N; Levens D
    J Virol; 1989 Apr; 63(4):1737-42. PubMed ID: 2538654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of circular unintegrated DNA of two types of the SEATO strain of gibbon ape leukemia virus.
    Gelmann EP; Trainor CD; Wong-Staal F; Reitz MS
    J Virol; 1982 Oct; 44(1):269-75. PubMed ID: 6292490
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.